Liwei Lang

1.4k total citations
52 papers, 940 citations indexed

About

Liwei Lang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Liwei Lang has authored 52 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Liwei Lang's work include Cancer, Hypoxia, and Metabolism (8 papers), Protein Degradation and Inhibitors (7 papers) and Epigenetics and DNA Methylation (5 papers). Liwei Lang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Protein Degradation and Inhibitors (7 papers) and Epigenetics and DNA Methylation (5 papers). Liwei Lang collaborates with scholars based in United States, China and Australia. Liwei Lang's co-authors include Yong Teng, Chloe Shay, Xiangdong Zhao, Lixia Gao, Yuanping Xiong, Reid Loveless, M C Pike, Ralph Snyderman, Austin Y. Shull and Xiuli Wang and has published in prestigious journals such as ACS Nano, PLoS ONE and Cancer Research.

In The Last Decade

Liwei Lang

47 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liwei Lang United States	20	564	202	173	120	87	52	940
Sandrine Billet United States	17	480 0.9×	144 0.7×	281 1.6×	204 1.7×	48 0.6×	32	1.1k
Hsiao‐Chi Tsai Taiwan	19	564 1.0×	246 1.2×	275 1.6×	187 1.6×	96 1.1×	31	1.0k
Min Cheng China	19	673 1.2×	423 2.1×	79 0.5×	137 1.1×	87 1.0×	57	1.1k
Maryam Rezaei Iran	19	450 0.8×	261 1.3×	137 0.8×	96 0.8×	46 0.5×	52	840
Dashnamoorthy Ravi United States	20	501 0.9×	153 0.8×	283 1.6×	128 1.1×	34 0.4×	51	961
Kamala Sundararaj United States	17	602 1.1×	174 0.9×	111 0.6×	217 1.8×	128 1.5×	26	1.1k
Karina G. Zecchin Brazil	21	740 1.3×	526 2.6×	248 1.4×	64 0.5×	64 0.7×	32	1.2k

Countries citing papers authored by Liwei Lang

Since Specialization

Citations

This map shows the geographic impact of Liwei Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Lang more than expected).

Fields of papers citing papers by Liwei Lang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liwei Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Lang. The network helps show where Liwei Lang may publish in the future.

Co-authorship network of co-authors of Liwei Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Liwei Lang. A scholar is included among the top collaborators of Liwei Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liwei Lang. Liwei Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Fanghui, Liwei Lang, Fan Yang, et al.. (2025). SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosis. Biomarker Research. 13(1). 8–8. 9 indexed citations

Yang, Xueyuan, Wei Yang, Fanghui Chen, et al.. (2024). Modulation of Dendritic Cell Function via Nanoparticle-Induced Cytosolic Calcium Changes. ACS Nano. 18(10). 7618–7632. 21 indexed citations

Chen, Fanghui, Liwei Lang, Fan Yang, et al.. (2024). Therapeutic Targeting of the GLS1–c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer. Cancer Research. 84(19). 3223–3234. 16 indexed citations

Lang, Liwei, et al.. (2024). Phosphodiesterase 9A inhibition improves aging-related increase in pulmonary vascular resistance in mice. GeroScience. 46(5). 5191–5202. 1 indexed citations

Lang, Liwei, Fanghui Chen, Yamin Li, et al.. (2023). Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer. Cancer Research Communications. 3(4). 659–671. 10 indexed citations

Tian, Yanna, Liwei Lang, Rongrong Wang, et al.. (2023). The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer’s disease. Frontiers in Molecular Neuroscience. 16. 1125932–1125932. 5 indexed citations

Lang, Liwei, Reid Loveless, Juan Dou, et al.. (2022). ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development. Journal of Experimental & Clinical Cancer Research. 41(1). 43–43. 25 indexed citations

Tian, Yanna, Liwei Lang, R. Daniel Rudic, et al.. (2021). Aging-induced impaired endothelial wall shear stress mechanosensing causes arterial remodeling via JAM-A/F11R shedding by ADAM17. GeroScience. 44(1). 349–369. 10 indexed citations

Chen, Hong, et al.. (2020). The Incidence and Predictors of Postoperative Delirium After Brain Tumor Resection in Adults: A Cross-Sectional Survey. World Neurosurgery. 140. e129–e139. 26 indexed citations

10.

Teng, Yong, Liwei Lang, & Chloe Shay. (2019). ATAD3A on the Path to Cancer. Advances in experimental medicine and biology. 1134. 259–269. 17 indexed citations

11.

Xiong, Yuanping, Leilei He, Chloe Shay, et al.. (2019). Nck-associated protein 1 associates with HSP90 to drive metastasis in human non-small-cell lung cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 122–122. 37 indexed citations

12.

Lang, Liwei, Chloe Shay, Xiangdong Zhao, et al.. (2019). Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma. Journal of Hematology & Oncology. 12(1). 132–132. 32 indexed citations

13.

Lang, Liwei, Austin Y. Shull, & Yong Teng. (2018). Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression. Current Cancer Drug Targets. 19(1). 17–25. 10 indexed citations

14.

Teng, Yong, et al.. (2017). The Complexity of DEK Signaling in Cancer Progression. Current Cancer Drug Targets. 18(3). 256–265. 11 indexed citations

15.

Lang, Liwei, et al.. (2015). Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds. Chemistry & Biology. 22(7). 957–964. 7 indexed citations

16.

Lai, Fangfang, et al.. (2014). [A novel HIF-1 inhibitor--manassantin A derivative LXY6099 inhibits tumor growth].. PubMed. 49(5). 622–6. 1 indexed citations

17.

Lang, Liwei, Xiaoyu Liu, Yan Li, et al.. (2014). A Synthetic Manassantin A Derivative Inhibits Hypoxia-Inducible Factor 1 and Tumor Growth. PLoS ONE. 9(6). e99584–e99584. 19 indexed citations

18.

Lang, Liwei, Chenyu Wang, Junhua Wu, et al.. (2010). Detection of residual toxin in tissues of ricin-poisoned mice by sandwich enzyme-linked immunosorbent assay and immunoprecipitation. Analytical Biochemistry. 401(2). 211–216. 16 indexed citations

19.

Lü, Lina, Xiuli Wang, Liwei Lang, & Fenghua Fu. (2010). Protective effect of reduced glutathione on the liver injury induced by acute omethoate poisoning. Environmental Toxicology and Pharmacology. 30(3). 279–283. 11 indexed citations

20.

Lang, Liwei, et al.. (1968). THE IMPLICATIONS OF A RISING FEMALE STERILIZATION RATE. BJOG An International Journal of Obstetrics & Gynaecology. 75(9). 972–975. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandrine Billet Breakdown of academic impact, for papers by Hsiao‐Chi Tsai Breakdown of academic impact, for papers by Min Cheng Breakdown of academic impact, for papers by Maryam Rezaei Breakdown of academic impact, for papers by Dashnamoorthy Ravi Breakdown of academic impact, for papers by Kamala Sundararaj Breakdown of academic impact, for papers by Karina G. Zecchin